The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

Please provide your email address to receive an email when new articles are posted on . Testing revealed significant cognitive differences between patients with Alzheimer’s or dementia and healthy ...

Alzheimer's disease is a heartbreaking and complicated condition, slowly taking away memory, thinking, and independence.

Researchers say the experimental tool has huge implications for public health, especially in conjunction with Alzheimer’s drugs that are most effective in the disease’s early stages ...

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that test ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

The U.S. FDA has approved Roche and Eli Lilly’s new Elecsys pTau181 blood test to help detect Alzheimer’s disease in people ...

A Corewell Health memory care clinic is working to bridge the gap in dementia detection and treatment for West Michigan’s ...

New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease. Latest Alzheimer's lab tests focus on memory loss, not brain plaques When doctors suspect ...